SMAD2 and pulmonary arterial hypertension: Chen et al. showed that activation of the TGF-β1/Smad2 signaling pathway promoted fibroblast transformation to a proliferative phenotype and adventitial fibrosis by upregulating α-SMA and COL1A1, which led to pulmonary arterial remodeling and PAH [33].